The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies The meeting was the first made up of RFK Jr.'s new hand-selected members.

And this week, CDC scientists presented data from the 2024-2025 season that showed RSV hospitalizations fell 28% to 43% among infants aged 0 to 7 months, compared with pooled rates from 2018 to 2020.

June 26 (UPI) -- Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

Pebsworth said she worried about coadministration of the shot with other childhood vaccines, despite data presented by the CDC's Vaccine Safety Datalink showing that RSV antibody shots being given ...

Lyn Redwood, a nurse practitioner who once led anti-vaccine organizations, presented on thimerosal in flu vaccines Thursday at a meeting of the CDC's Advisory Committee on Immunization Practices.

The new drug was approved this month by the FDA, and the CDC committee’s recommendation was the next step in making it widely available for the coming RSV season, which typically begins in the fall.

New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies Updated: 7:41 AM PDT Jun 26, 2025 Editorial Standards ⓘ By Meg Tirrell, CNN ...

New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies Updated: 10:41 AM EDT Jun 26, 2025 Editorial Standards ⓘ By Meg Tirrell, CNN ...